AnnMarie Liapakis, MD
, associate professor of medicine (digestive diseases) and surgery (transplantation); and Medical Director, Living Donor Liver Transplantation, is honored Nov. 18 by Donate Life Connecticut at a virtual gala honoring transplant “superheroes.” Liapakis has worked in the liver transplant program at Yale since 2012, evaluating and following liver transplant donors and recipients. She is involved in numerous clinical research projects, including the transplantation of patients with hepatitis C or the reception of organs positive for hepatitis C, and the fight against frailty to optimize the results of transplantation.Llor and Hofstatter co-publish cancer book with Yale contributors
Xavier Llor, MD, PhD, professor of medicine (digestive diseases), and Erin Hofstatter, MD, adjunct associate professor of medical oncology, are co-editors of the recently published book Cancer genetics: a clinical approach, a comprehensive review of clinical cancer genetics with top experts from many institutions, published by McGraw Hill. Contributors to Yale’s Genetics and Cancer Prevention Program and Department of Internal Medicine were: Rosa Xicola, PhD, Assistant Professor of Medicine (Digestive Diseases); Allen Bale, MD, professor of genetics; James Farrell, MBChB, professor of medicine; Elena Ratner, MD, associate professor of obstetrics, gynecology and reproductive sciences; Amy Killie, MS, CCG, and Kari Brierly, CCG, genetic counsellors; and Amanda Ganzak, JCC, senior genetic counselor.
Perry will give a keynote address at the City of Hope session
Rachel Perry, PhD, assistant professor of medicine (endocrinology) and cellular and molecular physiology, will deliver the keynote address for City of Hope’s “Diabetes and Cancer Interface—Connecting the Dots” session on November 1. His topic will be “An iMOONSHOT Approach to Understand the Links Between Obesity, Immunometabolism, and Cancer.”
Yale Internal Medicine Associates Receives National Patient-Centered Medical Home Recognition
Yale Internal Medicine Associates again received Patient-Centered Medical Home recognition from the National Committee for Quality Assurance (NCQA). Level 3 is the NCQA’s highest level of recognition.
